XtalPi
PublicXtalPi is now publicly traded
The data on this page reflects XtalPi's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 13, 2024
Last Round
Follow-on Offering
Feb 19, 2025
Total Funding Raised
$1.18B
Company Overview
XtalPi operates in Healthcare and is based in Cambridge, Massachusetts. Its recorded funding history includes a Series D round in August 2021.
XtalPi is a research platform company that utilizes artificial intelligence (AI), quantum physics, and robotics to accelerate research and development in the life sciences and new materials industries. The company's Intelligent Digital Drug Discovery and Development (ID4) platform provides predictive models to improve the efficiency and success rate of drug discovery. It offers services and products to pharmaceutical, biotechnology, and chemical companies worldwide, with operations in both China and the United States. Founded in 2015 by physicists from MIT, the company went public on the Hong Kong Stock Exchange in June 2024.
Sector
Healthcare
AI Layer
Application
XtalPi Comparables
Compare XtalPi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 88% | |
| Schrödinger | 83% | |
| Recursion Pharmaceuticals | 83% |
For institutional investors. Book with your work email.
XtalPi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Feb 19, 2025 | ||||
| IPO | Jun 13, 2024 | ||||
| Series D | Aug 11, 2021 | ||||
| Series C | Sep 28, 2020 | ||||
| Series B Extension | Oct 24, 2018 | ||||
Series B | Jan 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
XtalPi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series C |
| Yael Capital | Series B Extension |
| Mirae Asset | Series C |
| People's Insurance Company of China | Series C |
| CITIC Capital | Series C |
| 招银国际金融有限公司 | Series C |
| CITIC Securities | IPO |
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 10, 2026
At Dubai World Health Expo in United Arab Emirates in 2026, XtalPi Inc. shows the fully automated herbal medicine research platform it helps build for Hengqin Laboratory.
- partners_withOct 29, 2026
XtalPi Inc. partners with A*STAR International under MARVEL-AI to advance materials discovery and commercial translation through laboratory automation, joint research facilities, computational and experimental research, and talent exchange in Singapore on Oct 29th '26.
- attends_eventOct 29, 2026
XtalPi Inc. joins a select group of companies signing strategic agreements at Singapore Week of Innovation and Technology (SWITCH) 2026 in Singapore on Oct 29th '26, marking its inaugural participation in the event.
- partners_withOct 29, 2026
XtalPi Inc. partners with EDDC in Singapore since 2022 to advance targeted oncology therapies and automated synthesis.
- has_valuation_decreased_byOct 12, 2026
XtalPi Inc. records a valuation decrease of over 23% in five days as an AI drug discovery pullback tests its valuation anchor.
For institutional investors. Book with your work email.
XtalPi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.